TALARIUS LIMITED
Company number 05382157 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: TALARIUS LIMITED
1. Financial Health Score: B+ (Stable but Dormant)
Explanation: TALARIUS LIMITED presents as a financially stable entity with no signs of distress, but its dormant status means it is not actively “exercising” its financial muscles. The company has a substantial share capital base (£102.5M) and is fully compliant with filing deadlines. However, the absence of trading activity and detailed financial statements limits a deeper diagnosis. Think of it as a patient with a strong constitution who is currently in a medically induced coma—vitals are stable, but we cannot assess functional capacity without more data.
2. Key Vital Signs
| Vital Sign | Value / Status | Interpretation |
|---|---|---|
| Share Capital | £102,546,456 | A large equity base suggests historical investment or group restructuring. In a dormant company, this may simply be a nominal balance rather than liquid resources. |
| Accounts Category | Dormant | No significant financial transactions during the year. The company is not trading, generating revenue, or incurring operating costs. |
| Filing Compliance | Accounts due 30 Sep 2027; Confirmation Statement due 14 Jan 2027 – both not overdue | Excellent compliance health. No penalties or regulatory red flags. |
| Ownership | Novomatic UK Ltd owns >75% of shares and voting rights | The company is a subsidiary within a larger group. Its financial health is intrinsically linked to the parent’s stability. |
| Business Activity | SIC 64209 – Activities of other holding companies | The company’s purpose is to hold investments, not to trade. Dormancy is consistent with a passive holding entity. |
| Liabilities | Not disclosed (typical for dormant accounts) | Dormant accounts usually show minimal or no creditors. Solvency is not in question. |
3. Diagnosis
Asymptomatic dormant holding company with strong compliance and solvency, but limited transparency.
- No symptoms of financial distress: There are no overdue filings, no liquidation or administration flags, and no evidence of creditor pressure. The company is “breathing” normally on the compliance front.
- Dormant status is the dominant feature: Like a patient in a coma, the company is stable but not active. It has no operating cash flow, no revenue, and no expenses. This is not inherently unhealthy for a holding company, but it means we cannot assess profitability, liquidity, or efficiency.
- Group dependency: The >75% ownership by Novomatic UK Ltd means TALARIUS is a cog in a larger machine. Its financial wellness is contingent on the parent’s health. If the parent suffers, this entity could be affected through intercompany balances or group restructuring.
- Transparency limitation: The absence of detailed financial statements (beyond share capital) makes it impossible to evaluate asset quality, investment values, or contingent liabilities. This is the equivalent of a doctor having only a patient’s height and weight—useful, but not enough for a full diagnosis.
4. Recommendations
- Maintain compliance hygiene – Continue filing accounts and confirmation statements on time. Set calendar reminders for the 2027 deadlines.
- Review dormant eligibility annually – Ensure the company still meets the criteria for dormant accounts (no significant accounting transactions). If it begins to hold active investments or receive dividends, it may need to file full accounts.
- Monitor parent company health – Since Novomatic UK Ltd controls the entity, keep an eye on the parent’s financial statements and group announcements for any signs of stress.
- Consider voluntary transparency – If stakeholders require assurance, consider filing voluntary consolidated or group accounts (if applicable) to provide a clearer picture of the company’s investments and net asset position.
- Document intercompany arrangements – If there are loans or balances with the parent or subsidiaries, ensure they are properly recorded and disclosed, even if dormant.
- Periodic “health check” – Conduct an annual internal review of the company’s purpose and structure to confirm that dormancy remains appropriate and that no hidden liabilities have emerged.